Colorectal Cancer Screening Guidelines

Evidence Supporting FIT Superiority

The American Gastroenterological Association recommends FIT as the preferred stool-based screening test over gFOBT for adults over 50 at high risk of colorectal cancer, with significantly higher sensitivity for detecting both cancer and advanced neoplasia while maintaining comparable specificity 1, 2, 3
FIT demonstrates 2-3 times higher sensitivity for cancer detection compared to gFOBT, with cancer detection rates of 75-100% versus 30.8-64.3% for gFOBT across multiple studies 1, 2
FIT achieves 27.3-37.7% sensitivity for advanced adenomas compared to only 7.2-15.2% for gFOBT 1, 2
FIT maintains high specificity (85.9-96.9%) that is comparable to or only slightly lower than gFOBT (90.1-98.8%) 1, 2, 3
At equivalent positivity rates (5%), FIT achieves positive predictive values of 41-52% versus only 17% for gFOBT 3

The U.S. Multi-Society Task Force on Colorectal Cancer designates annual FIT as a first-tier screening option alongside colonoscopy (strong recommendation, moderate-quality evidence) 4, 5
The American Cancer Society recommends FIT as an acceptable high-sensitivity stool-based test for adults aged 45 years and older 6, 4
The Canadian Task Force on Preventive Health Care recommends FOBT (either gFOBT or FIT) every 2 years, but the evidence clearly favors FIT when choosing between them 7, 4

The U.S. Multi-Society Task Force recommends offering colonoscopy every 10 years as the first choice for average-risk adults aged 50-75 years (or 45+ per ACS guidelines) 4, 5
If colonoscopy is declined, offer annual FIT as the preferred stool-based test (not gFOBT) 4, 5
If FIT is positive, proceed immediately to diagnostic colonoscopy 8, 4

Never use FIT or any stool-based test in symptomatic patients (those with alarm symptoms like narrowed stools, rectal bleeding, unexplained weight loss) - these patients require immediate diagnostic colonoscopy regardless of FIT results 9
Do not use gFOBT when FIT is available - the evidence overwhelmingly favors FIT for both detection rates and patient adherence 1, 2, 3
Ensure patients understand that positive FIT results mandate colonoscopy follow-up - without this commitment, stool-based screening programs are ineffective 10
Do not continue screening past age 85 years or in patients with life expectancy <10 years, as harms outweigh benefits 7, 4

The American College of Physicians recommends offering FIT (or high‑sensitivity gFOBT) every 2 years for average‑risk adults, noting that the evidence strongly favors FIT over gFOBT. 11

Annual FIT testing is advised for average‑risk adults starting between ages 45–50 and continuing through age 75. 11

Colonoscopy performed every 10 years should be presented as the first‑choice screening option for average‑risk adults, because it allows direct visualization and therapeutic intervention. 11